Peel Therapeutics logo

Peel Therapeutics jobs and careers

About Peel Therapeutics

Peel Therapeutics is a clinical-stage biotech business that is creating drugs to improve the lives of patients. Peel (Hebrew for "elephant") began by focusing on cancer-fighting proteins in elephants, and we rapidly realized the power of leveraging evolution's answers to treat and prevent disease. In addition to producing elephantp53 (EP53) nanoparticles for cancer treatment, our team is expanding new cancer and inflammation medicines derived from nature's superpowers.

Founded in 2015 by Joshua Schiffman.

Founded
2015
Employees
11 to 50
Total funding
$25.1M

Leadership

The top of Peel Therapeutics's org chart, with how many people report into each leader.

JMPhoto of Joshua Schiffman, MD

Joshua Schiffman, MD

CEO and Co-Founder

4 reports

DV

Debra Vallner

SVP, Development Operations

2 reports

TFPhoto of Trent Fowler

Trent Fowler

Svp, Corporate Development